Tropical Diseases And Parasitic Diseases Conferences | Europe | Asia | Middle East | Canada | Japan | Australia | USA

Tropical Diseases and Parasitic Diseases

Tropical and parasitic diseases continue to pose major public health challenges, particularly in tropical and subtropical regions where environmental, socioeconomic, and climatic factors facilitate disease transmission. Neglected Tropical Diseases (NTDs), along with parasitic infections caused by protozoa and helminths, disproportionately affect vulnerable populations in low- and middle-income countries. This track focuses on the latest advances in epidemiology, diagnostics, therapeutics, vector control, vaccine development, and public health strategies to prevent and manage tropical and parasitic diseases while supporting global elimination efforts.

Market Analysis: The global tropical and parasitic disease diagnostics and therapeutics market is estimated to be valued at USD 3.8 billion in 2025 and is projected to reach approximately USD 6.1 billion by 2030, growing at a CAGR of 9.9% during the forecast period. Market growth is driven by increasing investments in neglected tropical disease (NTD) control programs, expanding access to rapid diagnostics, rising funding from global health organizations, and advancements in antiparasitic drug and vaccine development. North America and Europe continue to support research and innovation, while the Asia-Pacific, Africa, and Latin America regions are expected to witness the fastest growth due to higher disease prevalence, improving healthcare infrastructure, and strengthened disease surveillance initiatives.

Tracks